×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
melanoma
1.000
GeneticVariation
CLINVAR
Clinical responses to selumetinib (AZD6244; ARRY-142886)-based combination therapy stratified by gene mutations in patients with metastatic melanoma.
22972589
2013
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
melanoma
1.000
CausalMutation
CLINVAR
Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations.
23020132
2012
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
melanoma
1.000
CausalMutation
CLINVAR
Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial.
22608338
2012
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
melanoma
1.000
CausalMutation
CLINVAR
Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial.
22805292
2012
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
melanoma
1.000
GeneticVariation
CLINVAR
Improved survival with MEK inhibition in BRAF-mutated melanoma.
22663011
2012
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
melanoma
1.000
CausalMutation
CLINVAR
The HSP90 inhibitor XL888 overcomes BRAF inhibitor resistance mediated through diverse mechanisms.
22351686
2012
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
melanoma
1.000
CausalMutation
CLINVAR
Combinations of BRAF, MEK, and PI3K/mTOR inhibitors overcome acquired resistance to the BRAF inhibitor GSK2118436 dabrafenib, mediated by NRAS or MEK mutations.
22389471
2012
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
melanoma
1.000
CausalMutation
CLINVAR
Overwhelming response to Dabrafenib in a patient with double BRAF mutation (V600E; V600M) metastatic malignant melanoma.
23031422
2012
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
melanoma
1.000
GeneticVariation
CLINVAR
Phase II, open-label, randomized trial of the MEK1/2 inhibitor selumetinib as monotherapy versus temozolomide in patients with advanced melanoma.
22048237
2012
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
melanoma
1.000
CausalMutation
CLINVAR
Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial.
22735384
2012
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
melanoma
1.000
CausalMutation
CLINVAR
Phase II, open-label, randomized trial of the MEK1/2 inhibitor selumetinib as monotherapy versus temozolomide in patients with advanced melanoma.
22048237
2012
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
melanoma
1.000
CausalMutation
CLINVAR
BRAF(L597) mutations in melanoma are associated with sensitivity to MEK inhibitors.
22798288
2012
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
melanoma
1.000
CausalMutation
CLINVAR
Improved survival with MEK inhibition in BRAF-mutated melanoma.
22663011
2012
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
melanoma
1.000
CausalMutation
CLINVAR
A patient with BRAF V600E lung adenocarcinoma responding to vemurafenib.
22743296
2012
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
melanoma
1.000
GeneticVariation
CLINVAR
Overwhelming response to Dabrafenib in a patient with double BRAF mutation (V600E; V600M) metastatic malignant melanoma.
23031422
2012
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
melanoma
1.000
CausalMutation
CLINVAR
Kinase-impaired BRAF mutations in lung cancer confer sensitivity to dasatinib.
22649091
2012
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
melanoma
1.000
CausalMutation
CLINVAR
Dual suppression of the cyclin-dependent kinase inhibitors CDKN2C and CDKN1A in human melanoma.
22997239
2012
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
melanoma
1.000
CausalMutation
CLINVAR
Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib.
22356324
2012
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
melanoma
1.000
CausalMutation
CLINVAR
Routine multiplex mutational profiling of melanomas enables enrollment in genotype-driven therapeutic trials.
22536370
2012
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
melanoma
1.000
GeneticVariation
CLINVAR
Vemurafenib produced improved rates of overall and progression-free survival in patients with previously untreated melanoma with the BRAF V600E mutation.
21639808
2011
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
melanoma
1.000
GeneticVariation
CLINVAR
NRAS and BRAF mutation frequency in primary oral mucosal melanoma.
21750866
2011
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
melanoma
1.000
CausalMutation
CLINVAR
Vemurafenib produced improved rates of overall and progression-free survival in patients with previously untreated melanoma with the BRAF V600E mutation.
21639808
2011
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
melanoma
1.000
CausalMutation
CLINVAR
Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations.
21483012
2011
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
melanoma
1.000
CausalMutation
CLINVAR
RG7204 (PLX4032), a selective BRAFV600E inhibitor, displays potent antitumor activity in preclinical melanoma models.
20551065
2010
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
melanoma
1.000
CausalMutation
CLINVAR
Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF.
20141835
2010